Archive for the ‘Poland’ tag
Controloc control in Poland
ADHD disease awareness ad in Poland from Lilly
Objawy ADHD Wystepuja
Occurring ADHD symptoms

Generic name/category: Disease awareness
Company: Lilly
Country/Market: Poland, Europe
Indication(s)/use: Attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: Answers that matter.
Medium: Print ad
Size/duration: single-page
Publication/Aired: Gazeta Farmaceutyczn – June 2009
Alli in Poland
nowosc -
rewolucja w walce z nadwaga
New -
A revolution in the fight against weight

Orlistat (marketed as a prescription under the trade name Xenical by Roche or over-the-counter as Alli by GlaxoSmithKline), also known as tetrahydrolipstatin, is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. It is intended for use in conjunction with a physician-supervised reduced-calorie diet. Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to simplicity and stability, orlistat rather than lipstatin was developed into an anti-obesity drug.
The effectiveness of orlistat in promoting weight loss is definite, though modest. Pooled data from clinical trials suggests that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about 2–3 kilograms (4.4–6.6 lb) more than those not taking the drug. Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.

Brand name: Alli
Generic name/category: Orlistat, Antiobesity drugs, Lactones
Company: GlaxoSmithKline Consumer Healthcare (GSK)
Country/Market: Poland, Europe
Indication(s)/use: obesity
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: single-page
Publication/Aired: Gazeta Farmaceutyczna – September 2009
To see all of this brand’s ads on AdPharm, click here
Sympramol
Opipramol (Insidon, Pramolan) is a psychoactive drug widely used as an anxiolytic and antidepressant in Germany. Although it is a member of the tricyclic antidepressants (TCAs), opipramol's primary mechanism of action is much different in comparison. Most TCAs act as reuptake inhibitors, but opipramol does not, and instead acts as a sigma receptor agonist, among other properties.

Brand name: Sympramol
Generic name/category: Opipramol, Anxiolytics, Tricyclic antidepressants
Company: Symphar
Country/Market: Poland, Europe
Indication(s)/use: Depression and Anxiety
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: single-page
Publication/Aired: Gazeta Farmaceutyczna – September 2009
To see all of this brand's ads on AdPharm, click here
0 views
Sep 09, 2009
Visit AdPharm.net for more pharmaceutical ads
Actimel
Extra protection that nature didn’t give you.
Naturally strengthens human defenses.

Agency: Young and Rubicam Brands
Creative Director: Michal Imbierowicz
Art Director: Grzegorz Karwowski
Copywriter: Bartek Klimaszewski
Brand name: Actimel
Generic name/category: Lactobacillus casei, probiotic
Company: Danone
Country/Market: Poland, Europe
Indication(s)/use: Digestive and immune system
Target: Consumers (DTC)
Tagline: Naturally strengthens human defenses.
Publication: 2008
Clearasil
Say hello to your mirror
Clearasil is a brand of skin care and acne medication, whose products contain chiefly benzoyl peroxide, triclosan or salicylic acid as active ingredients. Clearasil has a wide range of products both for rapid acne treatment and for everyday prevention.
Clearasil was invented in the US in 1950 by Ivan Combe with the help of chemist Kedzie Teller. At this time it was the first dermatological brand created specially for young skin to fight against pimples (acne). The active ingredients in the original product were sulfur and resorcinol. – Wikipedia
Agency: EuroRSCG Warsaw
Creative Director: Jacek Szulecki
Art Director: Marcin Kruk
Copywriter: Alicja Wysocka
Photographer: Tomek Zieciowski
2009
SpecTab TV commercial
Propaganda-like commercial for Spectab, an alcohol effect reducer.
Credits:
Brand: SpecTab
Title: Onovalov’s Statue
Client: Jelfa
Spectab – a pill reducing effects of alcohol (Anti-Hangover remedy).
URL: SpecTab.pl
Advertising Agency: Change Integrated, Warsaw, Poland
Agency website: http://www.goforchange.pl
Creative Directors: Ryszard Sroka, Jakub Korolczuk, Rafal Gorski
Art Director: Adam Szczepocki
Copywriter: Franek Toeplitz
Sculpturer: Wojciech Zasadni
Others: Joanna Zielinska, Piotr Sroka, Konrad Grzegorzewicz, Radoslaw Duda, Adam Smereczynski, Marcin Trybulski, Maciek Topolski
Released: June 2008









